Atlas Trials

Intrathecal Ziconotide Antalgic Efficacy for Severe Refractory Neuropathic

Clinical trial NCT03942848 · UNKNOWN

Trial details

NCT number
NCT03942848
Sponsor
Hospices Civils de Lyon
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Severe Refractory Neuropathic PainSpinal Cord Lesions
Start date
2019-06-20
Primary completion
2019-12-20
Enrollment
44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.